To further explore the impact of decreased CD20 expression after relapse on survival time, 90 patients with recurrent ALL were analyzed and grouped according to the optimal threshold of the MFI and proportion of CD20 expression. Here, MS4A1 is linked to acute lymphoblastic leukemia.